Table 2.
Demographic and Clinical Characteristics of Participants Contributing a Blood Specimen
| Any Specimen (N = 486) | EDTA Testinga (n = 474) | SST Testingb (n = 460) | |
|---|---|---|---|
| Age | Median, (IQR) | Median, (IQR) | Median, (IQR) |
| 6.0, (2.5–11.8) | 6.1, (2.6–11.8) | 6.2, (2.8–11.7) | |
| Race | n, (%) | n, (%) | n, (%) |
| Asian | 18, 3.7 | 18, 3.8 | 18, 3.9 |
| Black | 55, 11.4 | 55, 11.6 | 51, 11.1 |
| Other | 24, 4.9 | 24, 5.1 | 22, 4.8 |
| Unknown/not reported | 25, 5.1 | 24, 5.1 | 21, 4.6 |
| White | 364, 74.9 | 353, 74.5 | 348, 75.7 |
| Ethnicity | |||
| Hispanic/Latino | 65, 13.4 | 64, 13.5 | 59, 12.8 |
| Not Hispanic/Latino | 413, 85.0 | 402, 84.8 | 393, 85.4 |
| Unknown/not reported | 8, 1.6 | 8, 1.7 | 8, 1.7 |
| Gender | |||
| Female | 239, 49.2 | 231, 48.7 | 224, 48.7 |
| Male | 247, 50.8 | 243, 51.3 | 236, 51.3 |
| Underlying Condition c | |||
| Cardiac disorders | 31, 6.4 | 28, 5.9 | 28, 6.1 |
| Genetic/metabolic/congenital disorders | 42, 8.6 | 40, 8.4 | 38, 8.3 |
| Hematologic malignancy | 158, 32.5 | 156, 32.9 | 154, 33.5 |
| Intestinal failured | 93, 19.1 | 92, 19.4 | 86, 18.7 |
| Neurologic disorders | 36, 7.4 | 34, 7.2 | 32, 7.0 |
| Respiratory disorders | 42, 8.6 | 39, 8.2 | 37, 8.0 |
| Solid organ transplant | 31, 6.4 | 30, 6.3 | 29, 6.3 |
| Solid tumor malignancy | 114, 23.5 | 113, 23.8 | 112, 24.3 |
| Stem cell transplant | 46, 9.5 | 42, 9.2 | 42, 9.1 |
| Surgery/Trauma in the last 2 weeks | 45, 9.3 | 42, 8.9 | 43, 9.3 |
| Othere | 23, 4.7 | 23, 4.9 | 20, 4.3 |
| Previously healthy | 1, 0.2 | 1, 0.2 | 1, 0.2 |
Abbreviations: EDTA, ethylenediaminetetraacetic acid; IQR, interquartile range; SST, serum separator tube.
Used by T2Candida assay.
Used by Fungitell, Platelia Candida Antigen Plus and Platelia Candida Antibody Plus assays.
Sum of categories may be greater than the overall number of subjects because some subjects may have multiple underlying conditions.
Intestinal failure includes conditions such as short gut, bowel dismotility syndrome, etc.
Other includes: autoimmune disease, cutaneous disorders, endocrine disorders, inherited immunodeficiency, invasive infection, lymphatic disorders, prematurity, and renal disorders.